全文获取类型
收费全文 | 204篇 |
免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 3篇 |
妇产科学 | 5篇 |
基础医学 | 16篇 |
口腔科学 | 7篇 |
临床医学 | 11篇 |
内科学 | 47篇 |
皮肤病学 | 6篇 |
神经病学 | 23篇 |
特种医学 | 3篇 |
外科学 | 43篇 |
预防医学 | 6篇 |
眼科学 | 2篇 |
药学 | 17篇 |
中国医学 | 2篇 |
肿瘤学 | 17篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 5篇 |
2020年 | 1篇 |
2019年 | 5篇 |
2018年 | 5篇 |
2017年 | 1篇 |
2016年 | 8篇 |
2015年 | 4篇 |
2014年 | 13篇 |
2013年 | 11篇 |
2012年 | 13篇 |
2011年 | 28篇 |
2010年 | 18篇 |
2009年 | 12篇 |
2008年 | 12篇 |
2007年 | 9篇 |
2006年 | 8篇 |
2005年 | 3篇 |
2004年 | 6篇 |
2003年 | 7篇 |
2002年 | 6篇 |
2001年 | 4篇 |
2000年 | 8篇 |
1999年 | 5篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1986年 | 3篇 |
1984年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有211条查询结果,搜索用时 0 毫秒
61.
62.
Bartolazzi A Orlandi F Saggiorato E Volante M Arecco F Rossetto R Palestini N Ghigo E Papotti M Bussolati G Martegani MP Pantellini F Carpi A Giovagnoli MR Monti S Toscano V Sciacchitano S Pennelli GM Mian C Pelizzo MR Rugge M Troncone G Palombini L Chiappetta G Botti G Vecchione A Bellocco R;Italian Thyroid Cancer Study Group 《The lancet oncology》2008,9(6):543-549
63.
Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome 总被引:7,自引:0,他引:7
Gianotti L Pivetti S Lanfranco F Tassone F Navone F Vittori E Rossetto R Gauna C Destefanis S Grottoli S De Giorgi R Gai V Ghigo E Maccario M 《The Journal of clinical endocrinology and metabolism》2002,87(11):5052-5057
To clarify the impairment of the GH/IGF-I axis in obstructive sleep apnea syndrome (OSAS), in 13 adult male patients with OSAS (OSA) as well as 15 weight-matched patients with simple obesity (OB) and 10 normal lean male subjects (NS), we studied: 1) the GH response to GHRH (1 micro g/kg iv) plus arginine (30 g iv); and 2) the IGF-I and IGF binding protein-3 responses to a very low dose recombinant human (rh)GH treatment (5.0 microg/kg sc per day for 4 d). The GH response to arginine plus GHRH in OSA was lower than in OB (P < 0.05), which in turn was lower than in NS (P < 0.001). Basal IGF-I levels in OSA were lower than in OB (P < 0.05), which in turn were lower than in NS (P < 0.03). As opposed to OB and NS, in OSA a very low rhGH dose did not affect IGF-I. Adjusting for age and basal values, rhGH-induced IGF-I rise in OSA was lower than in OB (P < 0.01). IGF binding protein-3, glucose, and insulin levels in the three groups were not modified by rhGH. OSA show a more marked impairment of the maximal secretory capacity of somatotroph cells together with reduced IGF-I sensitivity to rhGH stimulation. These findings suggest that OSAS is connoted by a concomitant impairment of GH secretion and sensitivity. 相似文献
64.
Oleandri SE Maccario M Rossetto R Procopio M Grottoli S Avogadri E Gauna C Ganzaroli C Ghigo E 《Journal of endocrinological investigation》1999,22(2):134-140
Abdominal obesity is connoted by hyperinsulinism and insulin insensitivity, a trend toward glucose intolerance, hypoactivity of GH/IGF-I axis and alterations of hypothalamo-pituitary-adrenal (HPA) axis. It has been hypothesized that treatment with metformin (MET) and dexfenfluramine (DEX) could counteract those endocrine-metabolic alterations. Thus, we studied the effects of 3-month treatment with MET or DEX on anthropometric (BMI, WHR, FM and FFM), metabolic (basal and OGTT-induced glucose) and hormonal variables (IGF-I, DHEA-S, androstendione, testosterone, fT3, fT4, TSH, basal and OGTT-induced insulin) as well as on blood pressure in 28 normotensive patients with abdominal obesity (OB, 3 M, 25 F; 47.5+/-1.5 yr [mean+/-SE], BMI 35.4+/-1.1 kg/m2, WHR 0.98+/-0.04 and 0.86+/-0.07, in M and F, respectively). All patients were on balanced hypocaloric diet (1400 Kcal/day). Patients were randomly assigned to treatment with MET (no.=10, 500 mg twice daily po) or DEX (no.=10, 15 mg thrice daily po) or placebo (no.=8). Before treatment all groups had similar anthropometric, metabolic and hormonal values. After 3-month treatment with MET, DEX or placebo, weight, BMI and WHR reductions were similar in all groups (p<0.05 vs baseline in either group). In each group FFM/FM ratio showed non significant trend toward increase. No significant variations in metabolic and endocrine variables were recorded in each group after 1 and 3-month treatment. However, glucose tolerance, OGTT-induced insulin response, glucose/insulin ratio showed a similar trend toward improvement in all groups, while IGF-I, 24 h urinary cortisol, DHEA-S, androstendione, testosterone, thyroid hormone and TSH levels did not show any variation. Significant (p<0.02) and similar reductions of DBP, but not of SBP, levels were found in all groups. In conclusion, our findings demonstrate that, at least after 3-month treatment, metformin and dexfenfluramine do not modify the effects of diet on anthropometric, metabolic and hormonal parameters as well as on blood pressure in patients with abdominal obesity. 相似文献
65.
66.
Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19 下载免费PDF全文
Gorzalski Andrew J. Hartley Paul Laverdure Chris Kerwin Heather Tillett Richard Verma Subhash Rossetto Cyprian Morzunov Sergey Van Hooser Stephanie Pandori Mark W. 《生物医学研究杂志》2020,34(6):431-436
We sought to determine the characteristics of viral specimens associated with fatal cases, asymptomatic cases and non-fatal symptomatic cases of COVID-19. This included the analysis of 1264 specimens found reactive for at least two SARS-CoV-2 specific loci from people screened for infection in Northern Nevada in March-May of 2020. Of these, 30 were specimens from fatal cases, while 23 were from positive, asymptomatic cases. We assessed the relative amounts of SARS-CoV-2 RNA from sample swabs by real-time PCR and use of the threshold crossing value (Ct). Moreover, we compared the amount of human RNase P found on the same swabs. A considerably higher viral load was found to be associated with swabs from cases involving fatality and the difference was found to be strongly statistically significant. Noting this difference, we sought to assess whether any genetic correlation could be found in association with virus from fatal cases using whole genome sequencing. While no common genetic elements were discerned, one branch of epidemiologically linked fatal cases did have two point mutations, which no other of 156 sequenced cases from northern Nevada had. The mutations caused amino acid changes in the 3′-5′ exonuclease protein, and the product of the gene, orf8. 相似文献
67.
Lucas da Fonseca Roberti Garcia Michelle Alexandra Chinelatti Hebert Luis Rossetto Fernanda de Carvalho Panzeri Pires-de-Souza 《Journal of endodontics》2014
Introduction
The aim of this study was to evaluate the solubility and disintegration of EndoBinder (EB) containing 3 different radiopacifying agents, bismuth oxide (Bi2O3), zinc oxide (ZnO), or zirconium oxide (ZrO2), in comparison with gray mineral trioxide aggregate (GMTA) and white MTA (WMTA).Methods
Ten specimens of each cement were made in a stainless steel matrix (20 × 1.5 mm) according to Specification no. 57 of American National Standards Institute/American Dental Association: EB + Bi2O3, EB + ZrO, EB + ZnO, WMTA, and GMTA. The specimens were weighed on an accurate analytical scale and immersed in 50 mL distilled and deionized water at 37°C for 7 days. Afterwards, specimens were dried and weighed again to determine mass loss (%). Resulting solutions were analyzed in an atomic absorption spectrophotometer for identification and quantification of chemical elements released.Results
All cements presented mean values of solubility and disintegration above the American National Standards Institute/American Dental Association Specification no. 57. EB + Bi2O3 presented the lowest mass loss (5.08%) and WMTA (6.65%) the highest, with no statistically significant difference (P > .05). The release of several chemical elements was observed, mostly metal ions. Only GMTA and EB + Bi2O3 showed the presence of Cr, with significant difference (P < .05). EB + ZnO presented the highest levels of Pb, followed by WMTA (P < .05). For As, the cements presented different release levels, with EB + ZnO showing the highest and GMTA the lowest levels (P < .05). However, the amounts of As and Pb released were lower than the safe limit proposed by ISO 9917-1.Conclusions
Irrespective of the radiopacifying agents used, EndoBinder presented similar behavior to MTA. 相似文献68.
69.
70.